ACP guidance on PSA tests differs slightly from AAFP recommendations

04/24/2013 | AAFP News Now

New prostate cancer screening recommendations from the American College of Physicians differ slightly from those issued by the AAFP and the U.S. Preventive Services Task Force. The ACP calls for physicians to discuss the limited benefits and substantial harms of testing with patients ages 50 to 69 and perform screening only if a patient clearly asks for it, while the AAFP recommends against PSA screening in asymptomatic men of any age. USPSTF member Mark Ebell, M.D., said more research into PSA testing will help resolve uncertainty.

View Full Article in:

AAFP News Now

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park